Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Northstar Gold Signs MOU with Hunan Nonferrous Ltd. to Develop Gold Resource (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
SQI Diagnostics Inc
V.SQD.H
Healthcare
Medical Devices
SQI Diagnostics Inc. is a Canada-based company that is focused on lung health. The Company is engaged in the development and manufacturing of respiratory health and precision medicine tests that run on its fully automated systems. Its clinical solutions include Rapid Acute Lung Injury Diagnostic (RALI-Dx), lung transplant diagnostics, COVID-19 testing and surveillance testing solutions. Its...
RALI-Dx IL-6 Severity Triage Test and the RALI-fast IL-6 Severity Triage point of care (POC) Test each help clinicians identify which patients with SARS-CoV-2 are predicted to have a severe inflammatory response and should or should not be admitted to the hospital. Its RALI-Dx delivers results from the lab in less than an hour while RALI-fast delivers results at the patient point-of-care in about 15 minutes. The Company’s TORdx LUNG Test measures inflammation at the molecular level to assess the health of the donor lung. The Company is also focused on its organ transplant pipeline of products.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
TSXV:SQD.H - Post Discussion
SQI Diagnostics Inc
> Quantifying Antibodies - Critical Requirement
New Post
View:
Discussion
List
(494)
•••
FactFinder1994
X
View Profile
View Bullboard History
Post by
FactFinder1994
on Nov 09, 2020 8:11am
Quantifying Antibodies - Critical Requirement
As Vaccines begin to get distributed and administered there remain so many questions.
With less than 100% effectiveness, is the patient infected?....(and did the vaccine work?)
How long will the antibodies last from any given vaccine?
How long do the antibodies last after Covid infection?
What quantity of antibodies are needed in order to provide protection?
How much will the virus adapt over time?
How do you determine when someone needs an additional vaccine?
All of these questions are best answered with a quick, highly sensitive and accurate quantitative antibody test. Regardless of the Covid question, SQI's antibody test is poised to answer all of these ongoing questions.
Stay tuned and well informed!
(33)
•••
barryt34
X
View Profile
View Bullboard History
Comment by
barryt34
on Nov 09, 2020 10:16am
Could Sqi's test be used to see if you need the vaccine in the first place?
(494)
•••
FactFinder1994
X
View Profile
View Bullboard History
Comment by
FactFinder1994
on Nov 09, 2020 11:00am
PubMed.gov - Organ Scoring Recent articles on scoring of organs might provide some insight as to where we are going. Here is one such article below. Determining who gets what treatment when will largely be dictated by highly sensitive and accurate multiplex diagnostic tests that provide an objective measure of function/health, where historically these determinations were far more
...more
(838)
•••
mercedesman
X
View Profile
View Bullboard History
Comment by
mercedesman
on Nov 09, 2020 11:08am
Excellent point FF !! Not only should the medical focus its support (vaccines) on the degree of risk an individual might face from a (1) job perspective (e.g front line medical worker), and (2) from an age perspective (where there is an obvious higher rate of death from CV-19), BUT ALSO FROM (3) AN UNDERLYING HEALTH OF THE INDIVIDUAL PERSPECTIVE (e.g someone with existing lung issues, a heart
...more
(838)
•••
mercedesman
X
View Profile
View Bullboard History
Comment by
mercedesman
on Nov 09, 2020 11:00am
Of course Barry If you've been previously exposed to the virus and or you are a Covid recovered patient, presumably you would be less likely to be considered as a vaccine candidate. The issue with the vaccine is getting it out to the right population as quickly as possible, given limited supplies for likely most of 2021 and perhaps beyond. I coud easily see the mandate being - vaccine for
...more
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
EnviroGold Global Announces Appointment of Chief Operating Officer
Mining Player Sells Off Promising Project for Millions – Here's Where the Cash is Headed